

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Enkephalin M
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Paragon Biomedical | Clario
Deal Size : Inapplicable
Deal Type : Inapplicable
NP2 Enkephalin For Treatment of Intractable Cancer Pain
Details : NP2 Enkephalin is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Pain, Intractable.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 09, 2011
Lead Product(s) : Enkephalin M
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Paragon Biomedical | Clario
Deal Size : Inapplicable
Deal Type : Inapplicable
